Press releases
These press releases are intended for journalists and analysts/investors.
-
Statement on arachnoiditis and myelograms
GSK has the utmost sympathy for the people who are afflicted by arachnoiditis. It can be a very debilitating and painful condition
-
GSK responds to Cyclone Debbie
GSK has responded to the Queensland Cyclone Debbie emergency relief by providing two pharmacies in Bowen and Airlie Beach with a donation
-
Availability of Menveo (meningococcal ACWY vaccine)
GSK is experiencing a short-term supply constraint of Menveo® in Australia due to a recent increase in notifications of the meningococcal
-
GSK discloses $28,375 in payments to HCPs
GSK stopped paying healthcare professionals to speak about our prescription medicines and vaccines on 1 January 2016
-
GSK increases supply of Meningococcal B vaccine
Recently there has been a global increase in demand for Bexsero (meningococcal B) vaccine which is reflected in Australia as well
-
New research shows Australians aren’t taking ageing lying down
Over 50s keep up with active-wear obsessed millennials on the activity stakes*
-
New treatment option available January 1 2017 for patients with a form of severe asthma
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS
-
Santa’s prostate nightmare urges Australian men to act
What would happen to Christmas if Santa suffered prostate issues?
-
GSK invests to support female technology entrepreneurs
GSK Australia announced today that it will support BlueChilli’s ‘SheStarts’
-
GSK Consumer Healthcare to close Ermington manufacturing site in 2020
All entitlements are protected for the 223 employees whose jobs are affected, and the company will work through the next four years
-
Bexsero (Meningococcal B) vaccine availability (1)
Recently there has been a global increase in demand for Bexsero® (meningococcal B) vaccine which is reflected in Australia as well
-
GSK founding partner for Victorian Medicines Manufacturing Innovation Centre
GSK Australia today announced its financial and in-kind support for the Medicine Manufacturing Innovation Centre (MMIC)
-
Whooping cough vaccines availability update
BOOSTRIX®-IPV is a combined diphtheria-tetanus-acellular pertussis and polio virus vaccine used as a booster in adults and children 4-years
-
Anne Belcher to succeed Geoff McDonald as GSK Australia general manager
GSK Australia announced today that Mrs Anne Belcher will succeed Mr Geoff McDonald as general manager of GSK Pharmaceuticals in Australia
-
GSK publishes transfer of value report
Medicines Australia transparency improves understanding of the relationship between industry and healthcare professionals
-
Experts urge hay fever sufferers to get symptoms under control
Leading Australian lifestyle and media commentator Shelly Horton has sprung into action today launching a new health campaign urging people
-
Global survey finds parents need to short-circuit their own anxiety to better manage their child’s illness
Global survey finds parents need to short-circuit their own anxiety to better manage their child’s illness
-
A shot in the arm for a shot at gold
The Australian Women’s Football team received travel vaccinations free of charge as part of an agreement between GSK and the Australian
-
Bactroban (mupirocin) 2% Ointment supply
Following manufacturing issues, supply of Bactroban (mupirocin) 2% Ointment for the topical treatment of mild impetigo
-
Easier access to medicines for men with enlarged prostates following medicine reimbursement changes
Australian men with an enlarged prostate are set to benefit from changes to the Pharmaceutical Benefits Scheme (PBS) which now allows